| Identification | Back Directory | [Name]
3-(N-Methylamino)-L-alanine | [CAS]
15920-93-1 | [Synonyms]
L-Bmaa
(S)-BMAA
-Methylamino-L-alanine
3-Methylamino-L-alanine
B-METHYLAMINO-L-ALANINE
β-Methylamino-L-alanine
--Methylamino-L-alanine
β-N-Methylamino-L-alanine
3-(Methylamino)-L-alanine
L-Alanine, 3-(methylamino)-
3-(N-Methylamino)-L-Alanine
L-SS-(N-METHYLAMINO)ALANINE
L-β-(N-methylamino) alanine
3-(N-Methylamino)-L-alanine 97%
3-(N-Methylamino)-L-alanine USP/EP/BP
3-(Methylamino)-L-alaninehydrochloride
S(+)-β-Methyl-α,β-diaMinopropionic Acid
(S)-2-Amino-3-(methylamino)propanoic acid
2-Amino-3-(methylamino)propanoicAcid,BMAA
(S)-2-Amino-3-(methylamino)propionic acid
beta-N-Methylamino-L-alanine hydrochloride
(2S)-2-Amino-3-(methylamino)propanoic acid | [Molecular Formula]
C4H10N2O2 | [MDL Number]
MFCD08063270 | [MOL File]
15920-93-1.mol | [Molecular Weight]
118.13 |
| Hazard Information | Back Directory | [Definition]
ChEBI: A non-proteinogenic L-alpha-amino acid that is L-alanine in which one of the methyl hydrogens is replaced by a methylamino group. A non-proteinogenic amino acid produced by cyanobacteria, it is a neurotoxi
that has been postulated as a possible cause of neurodegenerative disorders of aging such as Alzheimer's disease, amyotrophic lateral sclerosis, and the amyotrophic lateral sclerosis/parkinsonism-dementia complex (ALS-PDC) syndrome of Guam. | [Biological Activity]
Neurotoxic glutamate agonist originally isolated from Cycas circinalis. Implicated in the pathogenesis of amyotrophic lateral sclerosis-Parkinsonism-dementia complex of Guam (Guam ALS-PD). |
|
|